<DOC>
	<DOCNO>NCT01237665</DOCNO>
	<brief_summary>This prospective open label single-arm , single-institution phase II clinical trial test efficacy neoadjuvant treatment IXO ( Irinotecan , Capecitabine [ Xeloda ] , Oxaliplatin ) follow chemoradiotherapy resection patient resectable non-metastatic primary rectal cancer stage cT3-T4 N0-N2 .</brief_summary>
	<brief_title>IXO ( Irinotecan , Xeloda , Oxaliplatin ) Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<criteria>General Pathologically confirm rectal adenocarcinoma T3 T4 N1 ( node ≥1 cm short axis ) adenocarcinoma rectum . ECOG performance status equal le 1 Male female patient , age ≥ 18 year ≤ 80 year Written inform consent Adequate haematological , liver , renal function Resectability Patients categorize resectable locally advanced cancer Favorable general condition Resectability Diagnosis metastatic disease Clear indication involvement pelvic wall ( ) , image . Peritoneal carcinomatosis , portal vein occlusion , ascites , nonregional lymph node Histology adenocarcinoma Obstructed rectal carcinoma without defunctionalizing colostomy Prior treatment Previously undergone treatment disease Prior chemotherapy colorectal cancer Prior chemotherapy malignancy past 12 month Prior radiotherapy skin cancer Concomitant use St John 's Wort Treatment investigational agent Current use fulldose warfarin therapeutic Other condition Confirmed suspect brain metastasis History evidence CNS disease Past current history malignancy Clinically significant cardiovascular disease Evidence bleed diathesis coagulopathy Known hypersensitivity study drug Serious , nonhealing wound , ulcer bone fracture Major surgical procedure significant traumatic injury within 28 day prior treatment Disease condition contraindicates use investigational drug Life expectancy le 5 year Inability unwillingness comply protocol Neuropathy ≥ Gr.2 History ulcerative colitis Crohn 's disease Pelvic abscess perforate pelvic carcinoma Pregnancy / Contraception Pregnancy lactation Positive serum pregnancy test within 7 day start study treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>locally resectable advanced adenocarcinoma rectum</keyword>
</DOC>